Search Results
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital/ University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by S C Clement in
Google Scholar
PubMed
Search for other papers by W E Visser in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by C A Lebbink in
Google Scholar
PubMed
Search for other papers by D Albano in
Google Scholar
PubMed
Search for other papers by H L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by A Czarniecka in
Google Scholar
PubMed
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Search for other papers by R P Dias in
Google Scholar
PubMed
Search for other papers by M P Dierselhuis in
Google Scholar
PubMed
Search for other papers by I Dzivite-Krisane in
Google Scholar
PubMed
Search for other papers by R Elisei in
Google Scholar
PubMed
Search for other papers by A Garcia-Burillo in
Google Scholar
PubMed
Search for other papers by L Izatt in
Google Scholar
PubMed
Search for other papers by C Kanaka-Gantenbein in
Google Scholar
PubMed
Search for other papers by H Krude in
Google Scholar
PubMed
Search for other papers by L Lamartina in
Google Scholar
PubMed
Search for other papers by K Lorenz in
Google Scholar
PubMed
Search for other papers by M Luster in
Google Scholar
PubMed
Search for other papers by R Navardauskaitė in
Google Scholar
PubMed
Search for other papers by M Negre Busó in
Google Scholar
PubMed
Search for other papers by K Newbold in
Google Scholar
PubMed
Search for other papers by R P Peeters in
Google Scholar
PubMed
Search for other papers by G Pellegriti in
Google Scholar
PubMed
Search for other papers by A Piccardo in
Google Scholar
PubMed
Search for other papers by A L Priego in
Google Scholar
PubMed
Search for other papers by A Redlich in
Google Scholar
PubMed
Search for other papers by L de Sanctis in
Google Scholar
PubMed
Search for other papers by M Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by A S P van Trotsenburg in
Google Scholar
PubMed
Search for other papers by F A Verburg in
Google Scholar
PubMed
Search for other papers by M Vriens in
Google Scholar
PubMed
Search for other papers by T P Links in
Google Scholar
PubMed
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK
Office for Rare Conditions, University of Glasgow, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by H M van Santen in
Google Scholar
PubMed
Background
Although differentiated thyroid carcinoma (DTC) is the most frequent endocrine pediatric cancer, it is rare in childhood and adolescence. While tumor persistence and recurrence are not uncommon, mortality remains extremely low. Complications of treatment are however reported in up to 48% of the survivors. Due to the rarity of the disease, current treatment guidelines are predominantly based on the results of small observational retrospective studies and extrapolations from results in adult patients. In order to develop more personalized treatment and follow-up strategies (aiming to reduce complication rates), there is an unmet need for uniform international prospective data collection and clinical trials.
Methods and analysis
The European pediatric thyroid carcinoma registry aims to collect clinical data for all patients ≤18 years of age with a confirmed diagnosis of DTC who have been diagnosed, assessed, or treated at a participating site. This registry will be a component of the wider European Registries for Rare Endocrine Conditions project which has close links to Endo-ERN, the European Reference Network for Rare Endocrine Conditions. A multidisciplinary expert working group was formed to develop a minimal dataset comprising information regarding demographic data, diagnosis, treatment, and outcome. We constructed an umbrella-type registry, with a detailed basic dataset. In the future, this may provide the opportunity for research teams to integrate clinical research questions.
Ethics and dissemination
Written informed consent will be obtained from all participants and/or their parents/guardians. Summaries and descriptive analyses of the registry will be disseminated via conference presentations and peer-reviewed publications.
Search for other papers by Rui M B Maciel in
Google Scholar
PubMed
Search for other papers by Cleber P Camacho in
Google Scholar
PubMed
Search for other papers by Lígia V M Assumpção in
Google Scholar
PubMed
Search for other papers by Natassia E Bufalo in
Google Scholar
PubMed
Search for other papers by André L Carvalho in
Google Scholar
PubMed
Search for other papers by Gisah A de Carvalho in
Google Scholar
PubMed
Instituto do Câncer do Estado de São Paulo, São Paulo, São Paulo, Brazil
Search for other papers by Luciana A Castroneves in
Google Scholar
PubMed
Search for other papers by Francisco M de Castro Jr in
Google Scholar
PubMed
Search for other papers by Lucieli Ceolin in
Google Scholar
PubMed
Search for other papers by Janete M Cerutti in
Google Scholar
PubMed
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Search for other papers by Tânia M B L Ferraz in
Google Scholar
PubMed
Search for other papers by Carla V Ferreira in
Google Scholar
PubMed
Hospital Santa Rita de Cássia, Vitória, Espírito Santo, Brazil
Search for other papers by M Inez C França in
Google Scholar
PubMed
Search for other papers by Henrique C R Galvão in
Google Scholar
PubMed
Search for other papers by Fausto Germano-Neto in
Google Scholar
PubMed
Search for other papers by Hans Graf in
Google Scholar
PubMed
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Search for other papers by Ilda S Kunii in
Google Scholar
PubMed
Search for other papers by Márcio W Lauria in
Google Scholar
PubMed
Search for other papers by Vera L G Leal in
Google Scholar
PubMed
Search for other papers by Susan C Lindsey in
Google Scholar
PubMed
Instituto do Câncer do Estado de São Paulo, São Paulo, São Paulo, Brazil
Search for other papers by Delmar M Lourenço Jr in
Google Scholar
PubMed
Search for other papers by Léa M Z Maciel in
Google Scholar
PubMed
Search for other papers by Patrícia K R Magalhães in
Google Scholar
PubMed
Search for other papers by João R M Martins in
Google Scholar
PubMed
Hospital Geral de Fortaleza, Fortaleza, Ceará, Brazil
Universidade de Fortaleza, Fortaleza, Ceará, Brazil
Search for other papers by M Cecília Martins-Costa in
Google Scholar
PubMed
Search for other papers by Gláucia M F S Mazeto in
Google Scholar
PubMed
Search for other papers by Anelise I Impellizzeri in
Google Scholar
PubMed
Search for other papers by Célia R Nogueira in
Google Scholar
PubMed
Faculdade de Ciências da Saúde de Barretos Dr. Paulo Prata, Barretos, São Paulo, Brazil
Search for other papers by Edenir I Palmero in
Google Scholar
PubMed
Search for other papers by Cencita H C N Pessoa in
Google Scholar
PubMed
Search for other papers by Bibiana Prada in
Google Scholar
PubMed
Search for other papers by Débora R Siqueira in
Google Scholar
PubMed
Escola Fiocruz de Governo, Fundação Oswaldo Cruz and Ministério da Saúde, Brasília, Distrito Federal, Brazil
Search for other papers by Maria Sharmila A Sousa in
Google Scholar
PubMed
Vall d’Hebron Institute of Oncology (VHIO), CIBERONC, Barcelona, Spain
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Search for other papers by Flávia O F Valente in
Google Scholar
PubMed
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
Search for other papers by Laura S Ward in
Google Scholar
PubMed
Search for other papers by Shana S Weber in
Google Scholar
PubMed
Search for other papers by Rita V Weiss in
Google Scholar
PubMed
Search for other papers by Ji H Yang in
Google Scholar
PubMed
Search for other papers by Magnus R Dias-da-Silva in
Google Scholar
PubMed
Instituto do Câncer do Estado de São Paulo, São Paulo, São Paulo, Brazil
Search for other papers by Ana O Hoff in
Google Scholar
PubMed
Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil
Search for other papers by Sergio P A Toledo in
Google Scholar
PubMed
Search for other papers by Ana L Maia in
Google Scholar
PubMed
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstrated that the RET mutation profile may vary according to the geographical area. In this study, we collected clinical and molecular data from 554 patients with surgically confirmed MTC from 176 families with MEN2 in 18 different Brazilian centers to compare the type and prevalence of RET mutations with those from other countries. The most frequent mutations, classified by the number of families affected, occur in codon 634, exon 11 (76 families), followed by codon 918, exon 16 (34 families: 26 with M918T and 8 with M918V) and codon 804, exon 14 (22 families: 15 with V804M and 7 with V804L). When compared with other major published series from Europe, there are several similarities and some differences. While the mutations in codons C618, C620, C630, E768 and S891 present a similar prevalence, some mutations have a lower prevalence in Brazil, and others are found mainly in Brazil (G533C and M918V). These results reflect the singular proportion of European, Amerindian and African ancestries in the Brazilian mosaic genome.